ENDOS Medical

Company Overview

Snapshot

Founded in July 2024 by Yaakov Kahlon, ENDOS Medical operates with 1–10 employees. The company is currently in the pre-funding stage, focusing on the pre-clinical development of its E-Sleeve system, a single-use device for endoscopic sleeve gastroplasty.

Business overview

ENDOS Medical is an early-stage medical device company specializing in innovative endoscopic technologies for obesity treatment. Its core product, the E-Sleeve system, is a minimally invasive device designed to simplify endoscopic sleeve gastroplasty (ESG) by reducing the need for manual suturing. This technology aims to make ESG more accessible, cost-effective, and suitable for outpatient settings, serving the broader healthcare and medical devices industries.

Company Intelligence Q&A

What is ENDOS Medical's primary focus?

ENDOS Medical is focused on developing innovative endoscopic technologies for the treatment of obesity, with its primary product being the E-Sleeve system.

When was ENDOS Medical founded?

ENDOS Medical was founded in July 2024.

What is the E-Sleeve system?

The E-Sleeve system is a single-use, minimally invasive device developed by ENDOS Medical, intended for performing endoscopic sleeve gastroplasty (ESG).

What stage of development is the E-Sleeve system currently in?

The E-Sleeve system is currently undergoing pre-clinical development, including prototype optimization and ex-vivo testing, with preparations for in-vivo studies underway.

What are ENDOS Medical's regulatory plans for the E-Sleeve system?

Regulatory planning for the E-Sleeve system is underway, targeting FDA 510(k) clearance and CE marking.